Skip to content

Opening book details…

About this Medicine article

Abciximab: Cost-effective survival advantage in clinical trials and clinical practice by John J. Young; Dean J. Kereiakes is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
John J. Young; Dean J. Kereiakes
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6744)
Published
2000
Field
Medicine (Health Sciences)

More by John J. Young; Dean J. Kereiakes

Browse all works by John J. Young; Dean J. Kereiakes